PRKCB and cardiac hypertrophy: A recent study has observed interaction between phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, which is known to cause physiological cardiac hypertrophy, and protein kinase C beta (PKCβ) 2, which is known to cause pathologic cardiac hypertrophy.